AI-generated summary
The authors studied bright light therapy (2600 to 2800 lux) in patients with anxious or melancholic depression linked to manic-depressive psychosis or schizophrenia, measuring urinary catecholamine excretion. They report that light therapy lowered adrenaline levels in melancholic depression while noradrenaline stayed unchanged, and that anxious patients showed a tendency toward normalized catecholamine levels. The authors note considerable individual variation in the adrenaline to noradrenaline ratio after treatment.
- Who or what was studied
- Patients with anxious (11) or melancholic (12) depression resulting from manic-depressive psychosis or schizophrenia
- Limits stated in the abstract
- The abstract reports small subgroups, marked individual fluctuations, and only tendencies toward normalization in anxious patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Depression, Lux. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.